Cytomedix Inc.'s AutoloGel(TM) System Highlighted in Hair Transplant Trade Journal

ROCKVILLE, Md., Feb. 23, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that the Company’s lead product, the AutoloGel™ System, is highlighted in the current issue of “Hair Transplant Forum International,” the bi-monthly publication of the International Society of Hair Restoration Surgery. The article is authored by internationally renowned hair restoration specialist, Robert J. Reese, D.O., and is titled, “Autologous Platelet Rich Plasma (PRP): What Do We Know? Important Concepts Relevant To Hair Restoration Surgery.”

MORE ON THIS TOPIC